Trump nominee to head up FDA made no commitments on abortion pill access
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to medication abortion as it is now, or changing prescribing guidelines, in response to questions from both Democrats and Republicans during his confirmation hearing Thursday.
Senators from a key health panel on Thursday bombarded Dr. Marty Makary, President Donald Trump’s nominee to run the Food and ...
Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...
Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration (FDA), appears before the Senate Health ...
Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.
Marty Makary, Trump’s pick for FDA commissioner, testifies before a Senate panel this morning. Follow STAT's live updates.
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
From STAT’s Elaine Chen: A federal judge this week ruled against a compounding trade group that wanted to continue making ...
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in his confirmation hearing on Thursday, aligning himself with the ...
Analysts at Jefferies see Makary as a positive for the rare disease space, given his support for accelerated approvals and ...
Marty Makary, President Donald Trump’s pick to oversee US food and drug regulation, faced pointed questions in a Senate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback